发明授权
- 专利标题: Drugs comprising porphyrins
- 专利标题(中): 药物包括卟啉
-
申请号: US609991申请日: 1984-05-14
-
公开(公告)号: US4649151A公开(公告)日: 1987-03-10
- 发明人: Thomas J. Dougherty , William R. Potter , Kenneth R. Weishaupt
- 申请人: Thomas J. Dougherty , William R. Potter , Kenneth R. Weishaupt
- 申请人地址: NY Buffalo
- 专利权人: Health Research, Inc.
- 当前专利权人: Health Research, Inc.
- 当前专利权人地址: NY Buffalo
- 主分类号: A61B5/00
- IPC分类号: A61B5/00 ; A61K31/40 ; A61K41/00 ; A61K49/00 ; A61K51/00 ; A61N5/06 ; A61P35/00 ; A61P43/00 ; C07D487/22 ; C07D519/00 ; C09B47/00 ; G02B6/04 ; G02B6/26 ; G02B6/42
摘要:
To obtain tumor-selective, photosensitizing drugs useful in the localization of neoplastic tissue and treatment of abnormal neoplastic tissue such as tumors, one of two methods is used. In the first method, a hydrolyzed mixture of the products of reaction of hematoporphyrin with acetic acid and sulfuric acid is cycled through a microporous membrane system to exclude low molecular weight products. In the second method, drugs are synthesized or derived from other pyrrole compounds. The drugs: (1) include two covalently bound groups, each with four rings, some of which are pyrroles such as phlorins, porphyrins, chlorins, substituted pyrroles, substituted chlorins or substituted phlorins, each group being arranged in a ring structure, connected covalently to another group and have a triplet energy state above 37.5 kilocalories per mole; (2) are soluble in water, forming an aggregate of over 10,000 molecular weight in water and have an affinity for each other compared to serum protein such that 10 to 100 percent remain self aggregated in serum protein; and (3) are lipophyllic and able to disaggregate and attach to cell plasma, nuclear membrane, mitochondria, lysosomes and tissue. The drug obtained by the first method has an empirical formula of approximately C.sub.68 H.sub.70 N.sub.8 O.sub.11 or C.sub.68 H.sub.66 N.sub.8 O.sub.11 Na.sub.4.
公开/授权文献
- US5121045A EMI proof battery pack for night vision goggles 公开/授权日:1992-06-09
信息查询